First, regarding both oxidant (XO) and antioxidant (CAT, GPx and SOD) enzymes (Figure 2), we found significant differences in PMNs and MNs from NDD-CKD patients relative to healthy controls. This evidence concerns the gene CAT and Neurodevelopmental delay.